Tumor Tissue Concentrations of the Proteinase Inhibitors Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) and Plasminogen Activator Inhibitor Type 1 (PAI-1) Are Complementary in Determining Prognosis in Primary Breast Cancer

This publication has 32 references indexed in Scilit:

• Complex roles of tissue inhibitors of metalloproteinases in cancer
  Oncogene, 2002
• New functions for the matrix metalloproteinases in cancer progression
  Nature Reviews Cancer, 2002
• Tissue Inhibitor of Metalloproteinase-1 Alters the Tumorigenicity of Burkitt’s Lymphoma via Divergent Effects on Tumor Growth and Angiogenesis
  The American Journal of Pathology, 2001
• Inactivation of Plasminogen Activator Inhibitor-1 by Specific Proteolysis with Stromelysin-1 (MMP-3)
  Journal of Biological Chemistry, 2000
• Tissue Inhibitor of Metalloproteinases-1 (TIMP-1) Binds to the Cell Surface and Translocates to the Nucleus of Human MCF-7 Breast Carcinoma Cells
  Biochemical and Biophysical Research Communications, 1999
• Inhibition of Endothelial Cell Migration by Gene Transfer of Tissue Inhibitor of Metalloproteinases-1
  Journal of Surgical Research, 1999
• Proteolytic Cleavage of Urokinase-Type Plasminogen Activator by Stromelysin-1 (MMP-3)
  Biochemistry, 1998
• Growth‐promoting activity of tissue inhibitor of metalloproteinases‐1 (TIMP‐1) for a wide range of cells A possible new growth factor in serum
  FEBS Letters, 1992
• Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity
  Nature, 1985
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding
  Analytical Biochemistry, 1976